Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.18632/oncotarget.19000 http://scihub22266oqcxt.onion/10.18632/oncotarget.19000 C5601796!5601796!28938700     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Oncotarget 2017 ; 8 (35): 59991-8 Nephropedia Template TP {{tp|p=28938700|t=2017. Liver cancers with stem/progenitor-cell features ? a rare chemotherapy-sensitive malignancy |pdf=|usr=}}{{28938700}} gab.com Text Liver cancers with stem/progenitor-cell features a rare chemotherapy-sensitive malignancy JO: Oncotarget http://www.kidney.de/pget.php?&tw=1&pmid=28938700 #FOAvip Primary liver tumors are a heterogeneous group of malignancies. Besides classical hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC), combined and intermediate forms of liver cancer exist and can express stem-cell markers like nuclear cell adhesion molecule (NCAM-1/CD56), c-kit (CD117) or epithelial cell adhesion molecule (EpCAM) together with high proliferative activity. Liver tumors with progenitor-cell features are associated with an unfavorable prognosis, but the phenotype has not resulted in therapeutic consequences so far.We report three patients with liver cancers with stem/progenitor-cell features that responded exceptionally well to chemotherapy. These encouraging results indicate that the identification of liver cancer with stem/progenitor-cell phenotype in a patient´s tumor might justify an attempt to treat the patient with chemotherapy. Further case studies and finally clinical trials will be necessary to determine the optimal treatment for patients with this rare form of liver cancer. Twit Text FOAVip Liver cancers with stem/progenitor-cell features a rare chemotherapy-sensitive malignancy ????Oncotarget http://www.kidney.de/pget.php?&tw=1&pmid=28938700 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28938700 #FOAvip English Wikipedia <ref>{{Cite pmid|28938700}}</ref> Liver cancers with stem/progenitor-cell features ? a rare chemotherapy-sensitive malignancy #MMPMID28938700 Köhler BC; Waldburger N; Schlamp K; Jäger D; Weiss KH; Schulze-Bergkamen H; Schirmacher P; Springfeld C Oncotarget 2017[Aug]; 8 (35): 59991-8 PMID28938700show ga Primary liver tumors are a heterogeneous group of malignancies. Besides classical hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC), combined and intermediate forms of liver cancer exist and can express stem-cell markers like nuclear cell adhesion molecule (NCAM-1/CD56), c-kit (CD117) or epithelial cell adhesion molecule (EpCAM) together with high proliferative activity. Liver tumors with progenitor-cell features are associated with an unfavorable prognosis, but the phenotype has not resulted in therapeutic consequences so far.We report three patients with liver cancers with stem/progenitor-cell features that responded exceptionally well to chemotherapy. These encouraging results indicate that the identification of liver cancer with stem/progenitor-cell phenotype in a patient´s tumor might justify an attempt to treat the patient with chemotherapy. Further case studies and finally clinical trials will be necessary to determine the optimal treatment for patients with this rare form of liver cancer. äLiver cancers with stem/progenitor-cell features ? a rare chemotherapy(epmc).pdf DeepDyve Pubget Overpricing